Complete Mesocolic Excision With Central Vascular Ligation Versus Standard Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis of Lymph-Node Harvest (Preprint)
Authors:
- Jorge MaldonadoJMJorge Maldonado
- Alexis Agustin Dunay SilvaASAlexis Agustin Dunay Silva
- Patricia Juana Mamani de la Cruz ChoquePCPatricia Juana Mamani de la Cruz Choque
- Sofia Duarte GantivaSGSofia Duarte Gantiva
- Sergio Antonio Barahona BotacheSBSergio Antonio Barahona Botache
- Daniel Gilberto González SantosDSDaniel Gilberto González Santos
Preprint
- 3 November 2026
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Complete mesocolic excision (CME) with central vascular ligation has been proposed to improve lymph-node harvest compared with standard colectomy for colon cancer, though prior reviews report inconsistent heterogeneity and safety findings. OBJECTIVE This review aims to comprehensively synthesize lymph-node harvest as the primary outcome across the most current available evidence comparing CME with standard colectomy. METHODS PubMed, Cochrane CENTRAL, and ScienceDirect were searched to August 2026 per PRISMA 2020 guidelines. Risk of bias was assessed using RoB 2 and ROBINS-I; certainty was rated using GRADE. Continuous outcomes were pooled as mean differences and dichotomous outcomes as risk ratios using random-effects models in Review Manager (RevMan), with heterogeneity assessed via I² and Tau². Studies reporting outcomes in incompatible formats were synthesized narratively alongside pooled estimates. RESULTS Eighteen studies were included. For lymph-node yield, eight studies (n=926 CME, 1,145 comparator) pooled as mean differences showed CME significantly increased yield (MD 6.62, 95% CI [4.40, 8.84]; I²=80%), reduced after confounder-based subgrouping (confound-free MD 8.78, I²=61%; confounded MD 4.14, I²=58%; p=.010); narratively, all remaining studies reporting yield as medians, graded exposure, or unpooled means also favoured CME without exception. For the ≥12-node threshold, four studies showed no overall difference (RR 1.07, 95% CI [0.95, 1.21]; I²=81%), becoming significant after excluding one outlying study (RR 1.13, 95% CI [1.02, 1.24]; I²=51%); two additional studies reported this narratively, one non-significant and one showing the largest individual effect (94.7% vs. 79.1%, p<.001). Node positivity showed no pooled difference across thirteen studies (RR 0.99, 95% CI [0.87, 1.13]; I²=47%), while narratively synthesized studies showed mixed, largely non-significant findings. Postoperative complications showed no difference across eight pooled studies (RR 1.00, 95% CI [0.88, 1.13]; I²=0%), corroborated narratively across nine further studies with only one exception showing higher non-severe morbidity. CONCLUSIONS CME consistently increases lymph-node harvest without increasing perioperative complications, though evidence certainty remains low-to-moderate and long-term oncological benefit is unconfirmed.Keywords
This publication has 35 references indexed in Scilit:
- The role of complete mesocolic excision with central vascular ligation in colon cancer surgery: A systematic review and meta-analysis of prospective trialsEuropean Journal of Surgical Oncology, 2026
- Robotic complete mesocolic excision versus conventional robotic right colectomy for right-sided colon cancer: a comparative study of perioperative outcomesSurgical Endoscopy, 2021
- Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysisEuropean Journal of Surgical Oncology, 2021
- Laparoscopic Colectomy vs Laparoscopic CME: a Retrospective Study of Two Hospitals with Comparable Laparoscopic ExperienceJournal of Gastrointestinal Surgery, 2021
- Metastasis to lymph nodes around the vascular tie worsens long-term oncological outcomes following complete mesocolic excision and conventional colectomy for right-sided colon cancerTechniques in Coloproctology, 2021
- Robotic complete mesocolic excision for transverse colon cancer can be performed with a morbidity profile similar to that of conventional laparoscopic colectomyTechniques in Coloproctology, 2020
- Total Mesorectal Excision Technique—Past, Present, and FutureClinics in Colon and Rectal Surgery, 2020
- 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort studyThe Lancet Oncology, 2019
- Short term results of complete (D3) vs. standard (D2) mesenteric excision in colon cancer shows improved outcome of complete mesenteric excision in patients with TNM stages I-IITechniques in Coloproctology, 2013
- Cancer Colon2013